Patent details

EP2358379 Title: BIODEFENSES USING TRIAZOLE-CONTAINING MACROLIDES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2358379
WO Application Number:
US2009061978
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP09822828.1
WO Publication Number:
WO2010048601
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
24/10/2009
Grant date:
16/12/2015
EP Publication Date:
24/08/2011
WO Publication Date:
29/04/2010
Claims Translations Received Date:
Claims Translation B1 Received Date:
02/03/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/11/2019
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
16/12/2015
EP B1 Publication Date:
16/12/2015
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
23/10/2029
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
16/12/2015
 
 

 

Name:
Cempra Pharmaceuticals, Inc.
Address:
6320 Quadrangle Drive, Suite 360, Chapel Hill, NC 27517, United States of America (US)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
02/03/2016
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

Name:
FERNANDES, Prabhavathi, B.
Address:
Chapel Hill, NC 27514, United States of America (US)

Priority

1

Priority Patent Number:
108134 P
Priority Date:
24/10/2008
Priority Country:
United States of America (US)

2

Priority Patent Number:
108112 P
Priority Date:
24/10/2008
Priority Country:
United States of America (US)

3

Priority Patent Number:
162109 P
Priority Date:
20/03/2009
Priority Country:
United States of America (US)

4

Priority Patent Number:
108168 P
Priority Date:
24/10/2008
Priority Country:
United States of America (US)

5

Priority Patent Number:
108110 P
Priority Date:
24/10/2008
Priority Country:
United States of America (US)

6

Priority Patent Number:
108137 P
Priority Date:
24/10/2008
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/70; A61K 31/7048; A61K 31/7052; A61P 31/04;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
23/20
Publication date:
03/06/2020
Description:
Lapse or annulment

2

Bulletin Heading:
EP3
Journal edition number:
15/16
Publication date:
13/04/2016
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
51/15
Publication date:
16/12/2015
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201551
Publication date:
16/12/2015
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
16/10/2018
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
400 Euro
Payer:
Envoy International Limited
Filing date Document type Document Description Number of pages File Type
02/03/2016 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /6/3/6/9/1/0800019636/docs/ep09822828.1_0_incomingcorrespondenceelectronic20160302090905798.pdf
02/03/2016 Outgoing Correspondence Outgoing Letter 1 PDF /6/3/6/9/1/0800019636/docs/ep09822828.1_1_outgoingcorrespondence20160302090903049.pdf
02/03/2016 Claims Translated claims 3 PDF /6/3/6/9/1/0800019636/docs/ep09822828.1_2_claims20160302090905267.pdf